Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Rheumatoid Arthritis
Related Experiment Video
Updated: Jul 8, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Shaoxiong Zhang1, Shuo Sun1, Yajuan Zhang2
1The 6th Affiliated Hospital of Kunming Medical University, Yuxi, Yunnan, China.
Abstract:
m6A modification is the most abundant mRNA modifications and plays an integral role in various biological processes in eukaryotes. However, the role of m6A regulators in rheumatoid arthritis remains unknown. To determine the expression of m6A RNA methylation regulators in rheumatoid arthritis and their possible functional and prognostic value. In this study, we performed differential analysis in the comprehensive gene expression database GSE93272 dataset between non-rheumatoid arthritis patients and rheumatoid arthritis patients to obtain 15 important m6A regulators. A random forest model and lasso regression were used to screen the five most important m6A regulators to predict the risk of developing rheumatoid arthritis. After further validation using in vitro qPCR experiments, a nomogram model was developed based on the four most important m6A regulators (ELAVL1, WTAP, YTHDF1, and ALKBH5). Immuno-infiltration analysis and consensus clustering analysis were then performed. An analysis of the decision curve showed that the nomogram model could be beneficial to patients. According to selected important m6A regulators, patients with rheumatoid arthritis were classified into two m6A models (ClusterA and ClusterB) via consensus approach. Activated B cells, CD56dim natural killer cells, immature B cells, monocytes, natural killer T cells, and T lymphocytes were associated with ClusterA in immune infiltration analysis. Importantly, immune infiltration in patients with high ELAVL1 expression was strikingly similar to ClusterA. m6A regulators play a non-negligible role in the development of rheumatoid arthritis. A study of m6A patterns may provide future therapeutic options for rheumatoid arthritis.
Insights
This study identifies key N6-methyladenosine (m6A) regulators involved in rheumatoid arthritis (RA) development. These m6A regulators can predict RA risk and classify patients, offering potential new therapeutic targets for RA.
Area of Science:
- Epigenetics
- Immunology
- Molecular Biology
Background:
- N6-methyladenosine (m6A) modification is a prevalent mRNA modification crucial for eukaryotic biological processes.
- The specific role of m6A regulators in rheumatoid arthritis (RA) pathogenesis is not well understood.
Purpose of the Study:
- To investigate the expression patterns of m6A RNA methylation regulators in RA.
- To evaluate the functional and prognostic significance of these regulators in RA.
- To develop a predictive model for RA risk based on m6A regulators.
Main Methods:
- Differential gene expression analysis of the GSE93272 dataset to identify m6A regulators in RA patients.
- Machine learning models (random forest, lasso regression) for screening key m6A regulators.
- In vitro qPCR validation, nomogram construction, immuno-infiltration analysis, and consensus clustering.
Main Results:
- Fifteen m6A regulators were identified, with five selected for risk prediction.
- A nomogram model incorporating ELAVL1, WTAP, YTHDF1, and ALKBH5 demonstrated predictive utility.
- Consensus clustering revealed two distinct m6A-based patient subgroups (ClusterA and ClusterB) with differential immune cell infiltration.
- High ELAVL1 expression correlated with ClusterA immune infiltration patterns.
Conclusions:
- m6A regulators play a significant role in the development and progression of rheumatoid arthritis.
- m6A modification patterns represent a promising area for future RA therapeutic strategies.
- The developed nomogram model shows potential clinical benefit for RA patients.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
RNA Editing

